Skip to main content

Reta (Retatrutide) Research Peptides

★★★★★4.9(38)

Reta is the shorthand researchers use for retatrutide (LY3437943), a triple receptor agonist targeting GLP-1, GIP, and Glucagon receptors simultaneously, and the most potent compound in its class currently in clinical development. Phase 2 data published in the New England Journal of Medicine (2023) reported mean body weight reductions of up to 24.2% at the highest dose cohort over 48 weeks, surpassing outcomes seen with dual or single-receptor agents in equivalent trials.

The compound's triple mechanism drives energy expenditure through glucagon receptor activation while simultaneously suppressing appetite and improving insulin sensitivity via GLP-1 and GIP pathways. Phase 3 TRIUMPH trials are underway globally as of 2026. RetaLABS stocks research-grade reta peptide (retatrutide) in 10mg, 20mg, and 30mg vials for laboratory research use only.

For full mechanistic detail and trial data, see the Retatrutide Research Guide. For reconstitution and storage, see the Peptide Reconstitution Guide.

Frequently Asked Questions

Everything you need to know about Retatrutide

Research Guides

Retatrutide Molecular Profile: Formula, Weight, CAS Number, Sequence and Structure

8 min read

Retatrutide Australia 2026: Research Guide, Mechanism, Trial Data & Reconstitution

15 min read

Retatrutide 2026: Phase 3 Trials and What Researchers Should Know

17 min read

Retatrutide vs Tirzepatide: Triple vs Dual GLP-1 Agonism in Research

8 min read

Buying Research Peptides with Crypto in Australia: A Practical Guide

5 min read

Retatrutide Dosing Protocol: Phase 2 Trial Reference for Researchers

8 min read

GLP-1 and lean mass loss: what the clinical data actually shows: and why the receptor mechanism matters

16 min read

Why GLP-1 receptor agonists drive lean mass loss: the physiology behind the body composition data

11 min read

Drugs studied to preserve muscle on GLP-1s: bimagrumab, enobosarm, and the activin–myostatin approach

11 min read

Retatrutide Dosage Protocol Australia: Phase 2 Dosing Schedule & Escalation Guide

10 min read

Retatrutide Side Effects: Phase 2 Safety Data for Australian Researchers

8 min read

Retatrutide vs Semaglutide: Mechanism, Efficacy, and Research Comparison

8 min read

Retatrutide Cost Australia: Price Guide, Value Considerations & Sourcing

6 min read

Is Retatrutide Legal in Australia? TGA Status, Research Use & Sourcing

7 min read

Retatrutide vs Tirzepatide Australia: Triple vs Dual Agonist Research Comparison

8 min read

Retatrutide Statistics 2026: Trial Numbers, Dose-Cohort Data & Phase 3 Enrollment

13 min read

Retatrutide Research in Australia: 2026 Annual Report

14 min read

Retatrutide Research Papers: Primary Source Index 2026

8 min read

Retatrutide FAQ: 50 Research Questions Answered

18 min read

Retatrutide TRIUMPH-1 Results (2026): What the Phase 3 Data Showed

9 min read

Buy Reta (Retatrutide) Research Peptide Australia | RetaLABS.is